Remtolumab
Remtolumab Uses, Dosage, Side Effects, Food Interaction and all others data.
Remtolumab is under investigation in clinical trial NCT02433340 (Phase 2, Multicenter, Open-Label Extension (OLE) Study With ABT-122 in Rheumatoid Arthritis Subjects Who Have Completed the Preceding M12-963 Study).
| Trade Name | Remtolumab |
| Generic | Remtolumab |
| Remtolumab Other Names | Remtolumab |
| Type | |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | September 19, 2023 at 7:00 am |
Innovators Monograph
You find simplified version here Remtolumab
